Abstract. Detecting glaucoma progression is crucial for assessing the effectivity of the treatment. This paper describes three methods for detecting progression related changes in polarimetric images of the retinal nerve fiber layer (NFL), both on a global and on a local scale. Detecting global changes proved not to be feasible due to poor reproducibility of the measurements at the pixel level. Local progression on the other hand could be detected. A distribution based approach did not work, but locating specific areas with minimum size and minimum NFL decrease did give relevant results. The described algorithm yielded a TPR of 0.42 and an FPR of 0.095 on our datasets. It proved to be able to outline suspect areas that show NFL reduction.
Introduction
Glaucoma is a common eye disease wherein the nerve fiber layer (NFL) deteriorates, eventually leading to blindness. One of the available methods to diagnose glaucoma is scanning laser polarimetry (SLP) [1] . This method is based on form birefringence of the NFL, which causes retardation of polarized light. A laser scans the retina and a retardation map is produced, corresponding to the thickness of the NFL. Large inter-individual NFL measurements are frequently encountered, due to the morphological variability of the NFL between patients [2] . (See figure 1 for examples of polarimetric images of the NFL.) This causes a wide range of normal values, making glaucoma detection based on these measurements a non-trivial task. This problem can largely be bypassed by taking advantage of a series of images of an individual patient. Analyzing these consecutive images enables accurate detection of changes of time because it provides an individual baseline for each patient [2] .
One of the possible applications of SLP is the detection of progression of glaucoma. Since progression is directly related to changes of the NFL over time, it is an obvious candidate for detection based on a series of images. We will differentiate between two different types of progression [3] . In the first type, diffuse loss of NFL is encountered. In the second type, specific parts of the NFL are thinning, resulting in local loss.
The goal of this research is to find a method to detect progression in polarimetric images of glaucomatous eyes. Unfortunately, there is no ground truth as far as progression concerns [4] . Based on a set images of healthy eyes and a set of images of eyes that certainly show progression, an optimally performing detection algorithm will be build.
Methods
The images were acquired with the GDx 1 , which uses SLP to assess the NFL thickness. The images are monochromatic with a size 256 x 256 pixels at a quantization of 8 bits per pixel with SNR≈30 dB. The SNR is estimated by 20 · log 10 ( r sn ), where r is the dynamic range of the image and s n is the estimated standard deviation of a region with a presumable constant signal. The viewing angle is 15
• ; the sampling density is approximately 59 pixels/mm. For the first type of progression, showing diffuse loss, our detection method is based on assessing the average change of the NFL. This method is described in section 2.2. The second type concerns local NFL loss and can be detected by either looking at the distribution of the difference between images (see section 2.3) or by locating specific areas that show NFL reduction (as described in section 2.4). All of these descriptions rely on the definitions given in section 2.1. Section 2.5 describes the method we used to optimally train the detection algorithms.
Definitions
The number of patients in the database of normals is N N , the glaucoma database contains N G patients. For patient i, the database contains N (i) images, ordered on acquisition date. The j-th image of the i-th patient, acquired at time t(i, j), will be denoted by I(i, j). For each patient with N (i) > 1, all images were registered to the first one, as described below. The value of a certain pixel k in the image I(i, j) is denoted by I(i, j, k). The difference d between a registered pixel in image j and in the first image in the series is defined by D(i, j, k) = I(i, j, k)−I(i, 1, k). k will often be omitted to denote the whole differential image.
For each (registered) image I(i, j), we have a set S(i, j) of eligible pixels. Non-eligible pixels are those on blood vessel areas (detected by the algorithm as described in [5] ), the optic disk (the circular area in the center of the image, where the optic nerve exits the eye [6] ) and measurement errors (such as the black lines on the top and the bottom of the images in figure 1 ). For the difference images, the set T (i, j) contains the common eligible pixels of the two corresponding images. The indices i and j will be dropped whenever this does not introduce ambiguity.
Registration. Registration was done in two steps. First, an initial registration was done based on the detected blood vessel masks (see [5] ) of both images. The goal function consisted of the sum of the result of an exclusive-or operator on both masks. Then, the images were further registered based on their intensity values. In this case, the sum of the absolute difference between the two gray value images was used as the goal function. In both cases, a MarquardtLevenberg algorithm was used for minimizing the goal function. Only rotation and translation were used as registration parameters.
Detecting Global Loss
For detecting global loss, the most important requisite is good reproducibility of the measurements. That is, two consecutive measurements of the NFL, acquired within such short time that no significant biological changes of the NFL have occurred, should show minimal difference.
With this assumption, an obvious measure for global change is the difference of the average of all eligible pixels in both images. Since this is equal to the average of the difference image, the global change is defined by
where |T | means the number of elements in set T . After testing this measure on the normal data set, an arbitrary boundary B g is defined by its corresponding false positive rate (see section 2.5). Then, for all images, the classifier will classify an image as progression if D g < B g and as normal otherwise.
Detecting Local Loss: Distribution Based
For local loss detection, we first look at the distribution of the pixels of the difference images. Assume two consecutive images of the same eye, without progression. The pixels in the difference image will follow a certain distribution. Now, if the second image shows local progression, the distribution will change, because a number of pixels will show a decrease of NFL. Once a representative normal distribution is defined based on the database of normals, a difference image can be tested against this distribution to detect any abnormalities.
The difference image contains both a global change (as defined by equation 1) and a local part
Testing of the distribution is done by measurements depending on the difference between cumulative distribution functions (cdf s). For this, a set U (i, j, x) of all eligible pixels in the image with a pixel value of at most x is defined by
Likewise, the set S N (x) containing all eligible pixels in the normal database with a pixel value of at most x:
By writing
the cdf of the pixel values x in D l (i, j) is defined. Based on the database of normals, a normal cdf F N is constructed:
The cdf of the image to be tested is then compared to the normal cdf. For this comparison, a suitable distance metric is needed. One such a distance metric is the Kolmogorov-Smirnov distance d KS [7] , defined as
It measures the absolute vertical distance between two cdf s, defined by F 1 (x) and F 2 (x). For our purpose, 
Detecting Local Loss: The Spatial Coherent Criterion
A specific area in the image is located that shows a reduction of NFL. An area of 90
• on the nasal side is ignored, since this area is clinically of little importance. The proposed criterion thus selects an area with a minimum size (θ area ) consisting completely of pixels with at least a minimum difference (θ diff ). Again, since our interest is in local changes, we use D l (i, j) (see equation 2). First, it is thresholded at θ diff . Then, if the resulting area is larger than θ area , the image is classified as showing progression.
The values of both parameters will by optimized with images of the normal database and images with progression. Subsequently, cross-validation will be used to assess the performance of the resulting algorithm.
Training and Validation
Unfortunately, there is no general ground truth for progression. In healthy eyes there is no progression by definition. In a limited number of glaucomatous eyes, there definitely is progression. However, an ophthalmologist cannot determine from a random series of images whether glaucoma is progressing or not. Therefore, training and validation of the algorithms can only be done on the images from healthy eyes (set A) and the limited set of definite progression (set B).
Based on the images of healthy eyes, we can define the false positive rate (FPR * ) as
where FP is the number of false positives and TN is the number of true negatives. An asterisk is added as a reminder of the fact that this is actually the FPR on the normal database (set A) instead of the database with glaucoma patients. Under the assumption that the changes encountered in normal eyes are similar to those in glaucomatous eyes (without progression), the FPR on the glaucoma database is equal to FPR * .
Some images of patients in the glaucoma database show progression. However, since a ground truth is unavailable, we do not know which ones they are. For set B, however, we do know that they show progression (see above); this does not imply that the other images do not show progression. Based on set B, we can define the true positive rate (TPR * ) as
where TP is the number of true positives and FN is the number of false negatives. Again, an asterisk is added to show that this is only the TPR on a limited set.
Training. Algorithms based on only one parameter will be trained by set A. The parameter of the algorithm will be set to the value that results in the specified FPR * . For algorithms based on more than one parameter, both sets will be used. First, all parameter sets resulting in the specified FPR * will be determined based on set A. Then, the parameter set that yields the highest TPR * , based on set B, will be selected to define the final algorithm.
Validation. In the framework above, validation is implemented by k-fold crossvalidation. For single parameter algorithms, set A is randomly divided in k subsets. For the i-th fold, all subsets except the i-th one are used to set the parameter such that the algorithm results in a specified FPR * . Then, TPR * i is calculated based on all data from set B and FPR * i is calculated based on the i-th subset of set A. The final estimates of TPR * and FPR * are the averaged values of each fold. If an algorithm takes multiple parameters, samples from both set A and set B are needed for training. Both set A and set B are randomly divided into k subsets. For the i-th fold, all subsets excluding the i-th one of both sets are used to set the parameters such that the algorithm results in a specified FPR 
Results
The normal database contained 812 images of 154 patients; the number of difference images was therefore 658. The glaucoma database contained 3351 images of 489 patients, resulting in 2862 difference images. The number of eyes with progression was 20, corresponding to 134 images or 114 difference images.
Global Loss
In figure 2, D g (i, j) is plotted against the interval between the first image and image j. The solid lines connect images from the same patient. The dashed line shows B g for an FPR * of 0.05, which is -6.5. One can clearly see the large variation of D g among different images of the same person. Therefore, 14% of the normal patients have one or more images below this value. Note that requiring multiple consecutive measurements below B g may solve this problem, but it would have a severe impact on the time between progression and detection.
If we apply B g to the group of glaucoma patients, as shown in figure 3, 7.5% of the images exceed this value, corresponding to 20% of the patients. This suggests that a patient with images that, at a certain moment, seem to show progression is very likely to be classified as non-progressive in subsequent images, as is shown by the solid lines. Apparently, the reproducibility of the GDx at the pixel level is insufficient for this purpose. Figure 4 shows a plot of the histogram of the Kolmogorov-Smirnov distance between F D l (i, j, x) and F N (x) (see equation 7) for healthy eyes. The dashed line shows the cut-off value B d of 0.15 that results in an FPR * of 0.05. If we apply this to the glaucoma patients (see figure 5) , 8% of the images show a larger distance than B d , or 25% of the patients. Compared to the global loss, the same problems arise, but even slightly worse.
Distribution Based
Inspection of the images with d KS > B d showed that their large d KS was due to other causes than progression. In some cases, a relatively small registration error resulted in a large d KS . In other cases, we found a difference in focus, resulting in large distribution abnormalities in the difference image. The effect in this case is somewhat similar to a difference of Gaussians (DoG) filter. Small changes between images can thus result in large differences in pixel value distribution. Spatial information is necessary to discriminate between these effects and true progression, in which a clustering of aberrant pixels is expected.
The Spatial Coherence Criterion
Preliminary tests showed that this method did produce relevant results. As an example, see figure 6 . Figure 6(a) shows the base NFL, figure 6(b) shows the registered and mean-adjusted test image and the difference, including the detection result, is shown in figure 6(c) .
Unfortunately, not all images of eyes with progression show this amount of NFL reduction. Due to the nature of progression, the first images of a progressive eye hardly shows any NFL reduction. On the other hand, images from the normal database sometimes show differences that exceed those in progression eyes. The poor performance, as shown by the ROC in figure 7(a) , is due to these effects. The ROC shows the TPR * (or sensitivity) and FPR * (or specificity) of the algorithm based on all images of the normal and progressive groups. The values are estimated by ten repeated runs of 10-fold cross-validation.
In practice, however, one is not interested in individual images, but in diagnosing eyes of patients. Therefore, an ROC based on eyes is shown in figure  7 significantly. A criterion that more closely resembles the clinical practice is one that requires reduction in more than one consecutive images. An ROC for such a criterion, based on three consecutive difference images, is also shown in figure 7(b) (solid line). For the area of interest (with low FPR * ), this further improves TPR * . Again, the values were estimated by cross-validation.
Conclusions and Discussion
We presented three methods for detecting progression. Detecting global loss proved to give unsatisfactory results, apparently due to the poor reproducibility of the GDx measurements at the pixel level. Local loss detection based on distributional differences between normal and progressive images failed. It proved to be sensitive to differences between images originating from other sources than progression. A spatial coherence criterion, however, produced relevant results. By searching for specific areas with a minimum size and a minimum decrease of NFL, detection of local loss proved to be possible. The algorithm yielded a TPR * of 0.42 with an FPR * of 0.095 on differentiating between healthy eyes and eyes that showed progression.
Obviously, the problem is a very difficult one. No ophthalmologist will be able to tell for sure whether a randomly selected eye shows progression. No ground truth is available and even some of the eyes in the normal group may some day prove to be abnormal. No automated method will therefore be able to duplicate the diagnosis of ophthalmologists. However, an algorithm that identifies areas that show NFL reduction may stimulate the ophthalmologist to further research those suspect areas and possibly reconsider the current treatment, preventing further visual field loss.
